Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study

MLA

Katsuhiko Hagi, et al. “Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-Week Open Label Extension Study.” Journal of Affective Disorders, vol. 281, Aug. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ab6a792b7338cd41d39ee2020654aec2&authtype=sso&custid=ns315887.

APA

Katsuhiko Hagi, Jun Ishigooka, Teruhiko Higuchi, Kei Watabe, Takahiro Masuda, Tadafumi Kato, & Mari Miyajima. (2020). Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study. Journal of Affective Disorders, 281.

Chicago

Katsuhiko Hagi, Jun Ishigooka, Teruhiko Higuchi, Kei Watabe, Takahiro Masuda, Tadafumi Kato, and Mari Miyajima. 2020. “Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-Week Open Label Extension Study.” Journal of Affective Disorders 281 (August). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ab6a792b7338cd41d39ee2020654aec2&authtype=sso&custid=ns315887.